RecruitingPhase 2NCT06665594

Effect of TXA on Reducing Bruising After Filler Injection

Does TXA Reduce Bruising After Hyaluronic Acid Filler Injection? A Prospective Half Face Study

Sponsor

University of Wisconsin, Madison

Enrollment

40 participants

Start Date

Dec 5, 2025

Study Type

INTERVENTIONAL

Conditions

Hyaluronic Acid Tranexamic Acid Facial Filler Injections

Summary

The goal of this clinical trial is to look at the effect tranexamic acid (TXA) may have on reducing bruising, swelling, and pain after facial filler injection. The main question it aims to answer is: * Does the addition of TXA to hyaluronic acid (HA) reduce bruising, swelling, and tenderness after HA injection? Participants will receive the study medication along with the standard facial filler injection and complete surveys.

Eligibility

Min Age: 18 YearsMax Age: 89 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Hyaluronic Acid (HA), a drug called Saline (placebo), and others for people with facial filler injections, hyaluronic acid, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.